Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- IB
- UC
- UC
- Ud
Lists including Jose
Investments
Work Experience
Partner
2023
2025
Board Director
2025
deepull is a development-stage clinical diagnostics company focusing on direct from blood sepsis diagnostics.
2025
Board Director
2025
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.
2024
Board Director
2024
2023
Board Director
2023
Developing microRNA modulators for diseases with unmet medical needs (DM1)
2024
Board Observer
2024
Revolutionary intracellular screening platform enables a new generation of first-in-class drugs.
2024
Director
2024
At Advanthera, we combine innovation, experience, and precision to bring advanced biotechnological solutions to the next development phase, ensuring they become readily accessible for the care of patients and caregivers, always upholding the highest standards of quality. From GMP-compliant development and manufacturing to pioneering research in new therapies, we work to ensure every breakthrough makes a real impact on people’s lives.
2020 - 2022
Board Director
2020 - 2022
Developing personalized adjuvant treatment strategies for early-stage breast cancer.
2020 - 2022
Board Director
2020 - 2022
Discovery and development of therapeutic biologics targeting the lipid metabolism in order to treat advanced cancer.
2020 - 2022
Board Director
2020 - 2022
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.